Emergent BioSolutions is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats.
Emergent develops and manufactures vaccines and therapeutics that address biological agents like anthrax, smallpox, and botulism as well as devices that address chemical warfare agents. Emergent has a 20-year track record of partnering with the U.S. and allied governments by providing preparedness solutions that support their national security plans. One of Emergent’s facilities is designated as a Center for Innovation in Advanced Development and Manufacturing, established through a multi-year partnership with the U.S. Department of Health and Human Services. This facility is designed with capabilities for surge manufacturing of medical countermeasures in the event of a public health emergency.
The company has approximately 1,600 employees dedicated to its mission – to protect and enhance life.